Dosimetry of inhaled nanoparticles

Nanoparticles in Medicine and Environment: Inhalation and Health Effects

Volumn , Issue , 2010, Pages 145-171

  Kreyling, Wolfgang G ^a   Geiser, Marianne ^b  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HAZARDOUS MATERIALS; HAZARDS; HEALTH; HEALTH RISKS; NANOPARTICLES;

ADVERSE HEALTH EFFECTS; ENGINEERED NANOPARTICLES; EXPOSURE ASSESSMENT; FINE AND ULTRAFINE PARTICLES; GROWING PRODUCTION; HAZARD IDENTIFICATION; RISK CHARACTERIZATION; RISK IDENTIFICATION;

RISK ASSESSMENT;

EID: 84919666239     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1007/978-90-481-2632-3_8     Document Type: Conference Paper

References (94)

1. Adamson IY, Bowden DH (1981) Dose response of the pulmonary macrophagic system to various particulates and its relationship to transepithelial passage of free particles. Exp Lung Res 2:165-175.
2. Alessandrini F, Semmler-Behnke M, Jakob T, Schulz H, Behrendt H, KreylingW(2008) Total and regional deposition of ultrafine particles in a mouse model of allergic inflammation of the lung. Inhal Toxicol 20:585-593.
3. Asgharian B, Hofmann W, Bergmann, R (2001a) Particle deposition in a multiple-path model of the human lung. Aerosol Sci Technol 34:332-339. Free public shareware is available at http://www.thehamner.org/mppd/helpfiles/index. htm.
4. Auerbach O, Conston A S, Garfinkel L, Parks VR, Kaslow HD, Hammond EC (1980) Presence of asbestos bodies in organs other than the lung. Chest 77:133-137.
5. Berry JP, Arnoux B, Stanislas G (1977) A microanalytic study of particles transport across the alveoli: role of blood platelets. Biomedicine 27:354-357.
6. Bianco A, Gibb FR, Kilpper RW, Landman S, Morrow PE (1974) Studies of tantalum dust in the lungs. Radiology 112:549-556.
7. Blank F, Rothen-Rutishauser B, Gehr P (2007) Dendritic cells and macrophages form a transepithelial network against foreign particulate antigens. Am J Respir Cell Mol Biol 36:669-677.
8. Bowden DH, Adamson IY (1984) Pathways of cellular efflux and particulate clearance after carbon instillation to the lung. J Pathol 143:117-125.
9. Brain JD, Gehr P, Kavet RI (1984) Airway macrophages. The importance of the fixation method. Am Rev Respir Dis 129:823-826.
10. Brown JS, Zeman KL, Bennett WD (2002) Ultrafine particle deposition and clearance in the healthy and obstructed lung. Am J Respir Crit Care Med 166:1240-1247.
11. Cedervall T, Lynch I, Lindman S, Berggard T, Thulin E, Nilsson H, Dawson KA, Linse S (2007) Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci USA 104:2050-2055.
12. Chen J, Tan M, Nemmar A, Song W, Dong M, Zhang G, Li Y (2006) Quantification of extrapulmonary translocation of intratracheal-instilled particles in vivo in rats: effect of lipopolysaccharide. Toxicology 222:195-201.
13. Cruts B, van Etten L, Tornqvist H, Blomberg A, Sandstrom T, Mills NL, Borm PJA (2008) Exposure to diesel exhaust induces changes in EEG in human volunteers. Part Fibre Toxicol 5:5.
14. Cruz-Orive LM, Geiser M (2004) Estimation of particle number by stereology: an update. J Aerosol Med 17:197-212.
15. Cruz-Orive LM, Insausti A, Insausti R, Crespo D (2004) A case study from neuroscience involving stereology and multivariate analysis. In: Evans SM, Janson AM, Nyengaard JR (eds) Quantitative methods in neuroscience, Chapter 2, Practical Neuroscience Series, Oxford University Press, Oxford, UK, pp 16-64.
16. Duncan R (2006) Polymer conjugates as anticancer nanomedicines. Nat Rev Cancer 6:688-701.
17. Ellender M, Hodgson A, Wood KL, Moody JC (1992) Effect of bronchopulmonary lavage on lung retention and clearance of particulate material in hamsters. Environ Health Perspect 97:209-213.
18. ESF (2005) ESF forward look on Nanomedicine. European science foundation policy briefings, http://www.esf.org/newsrelease/83/SPB23Nanomedicine.pdf.
19. Ferin J, Oberdörster G, Penney DP (1992) Pulmonary retention of ultrafine and fine particles in rats. Am J Respir Cell Mol Biol 6:535-542.
20. Gehr P, Schürch S, Berthiaume Y, Im Hof V, Geiser M (1990) Particle retention in airways by surfactant. J Aerosol Med 3:27-43.
21. Geiser M (2002) Morphological aspects of particle uptake by lung phagocytes. Micr Res Tech 57:512-522.
22. Geiser M, Cruz-Orive LM, Im Hof V, Gehr P (1990) Assessment of particle retention and clearance in the intrapulmonary airways of hamster lungs with the fractionator. J Microsc 160:75-88.
23. Geiser M, Baumann M, Cruz-Orive LM, Im Hof V, Waber U, Gehr P (1994) The effect of particle inhalation on macrophage number and phagocytic activity in the intrapulmonary conducting airways of hamsters. Am J Respir Cell Mol Biol 10:594-603.
24. Geiser M, Im Hof V, Siegenthaler W, Grunder R, Gehr P (1997) Ultrastructure of the extracellular lining layer in hamster airways: is there a two-phase system? Micr Res Techn 36:428-437.
25. Geiser M, Gerber P, Maye I, Im Hof V, Gehr P (2000a) Retention of teflon particles in hamster lungs: a stereologic study. J Aerosol Med 13:43-55.
26. Geiser M, Leupin N, Maye I, Im Hof V, Gehr P (2000b) Interaction of fungal spores with the lungs: distribution and retention of inhaled Calvatia excipuliformis spores. J Allergy Clin Immunol 106:92-100.
27. Geiser M, Matter M, Maye I, Im Hof V, Gehr P, Schürch S (2003a) Influence of airspace geometry and surfactant on the retention of man-made vitreous fibers (MMVF 10a). Environ Health Perspect 111:895-901.
28. Geiser M, Schürch S, Gehr P (2003b) Influence of surface chemistry and topography of particles on their immersion into the lung's surface-lining layer. J Appl Physiol 94:1793-1801.
29. GeiserM, Rothen-Rutishauser B, Kapp N, Schürch S, KreylingW, Schulz H, Semmler M, Im Hof V, Heyder J, Gehr P (2005) Ultrafine particles cross cellular membranes by non-phagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect 113:1555-1560.
30. Geiser M, Casaulta M, Kupferschmid B, Schulz H, Semmler-Behnke M, Kreyling W (2008) The role of macrophages in the clearance of inhaled ultrafine titanium dioxide particles. Am J Respir Cell Mol Biol 38:371-376.
31. Gil J, Weibel ER (1971) Extracellular lining of bronchioles after perfusion-fixation of rat lungs for electron microscopy. Anat Rec 169:185-200.
32. Gunderson HJG (1978) Estimators of the number of objects per area unbiased by edge effects. Microsc Acta 81:107-117.
33. Howard CV, ReedM(2005) Unbiased stereology: three-dimensional measurement in microscopy, 2nd edn. Taylor & Francis Inc., Abingdon, UK.
34. Hulbert WC, Forster BB, Laird W, Pihl CE, Walker DC (1982) An improved method for fixation of the respiratory epithelial surface with the mucous and surfactant layers. Lab Invest 47:354-363.
35. Ibald-Mulli A, Wichmann HE, Kreyling W, Peters A (2002) Epidemiological evidence on health effects of ultrafine particles. J Aerosol Med 15:189-201.
36. ICRP Publication 66 (1994) Human respiratory tract model for radiological protection. A report of a Task Group of the International Commission on Radiological Protection. Ann ICRP 24 (1-3):1-482.
37. Im Hof V, Scheuch G, Geiser M, Gebhard J, Gehr P, Heyder J (1989) Techniques for the determination of particle deposition in lungs of hamsters. J Aerosol Med 2:247-259.
38. Im Hof V, Gehr P, Gerber V, Lee MM, Schürch S (1997) In vivo determination of surface tension in the horse and in vitro model studies. Respir Physiol 109:81-93.
39. Kapp N, Kreyling W, Schulz H, Im Hof V, Semmler M, Gehr P, Geiser M (2004) Identification of inhaled ultrafine titanium oxide particles by analytical electron microscopy in rat lungs. Microsc Res Techn 63:298-305.
40. Khandoga A, Stampfl A, Takenaka S, Schulz H, Radykewicz R, Kreyling W, Krombach F (2004) Ultrafine particles exert prothrombotic but not inflammatory effects on the hepatic microcirculation in healthy mice in vivo. Circulation 109:1320-1325.
41. Kreuter J (2001) Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev 47:65-81.
42. Kreuter J (2004) Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain. J Nanosci Nanotech 4:484-488.
43. Kreuter J, Shamenkov D, Petrov V, Ramge P, Cychutek K, Koch-Brandt C, Alyautdin R (2002) Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier. J Drug Target 10:317-325.
44. Kreyling WG (1990) Interspecies comparison of lung clearance of "insoluble" particles. J Aerosol Med 3:S93-S110.
45. Kreyling W, Scheuch G (2000) Clearance of particles deposited in the lungs. In: Heyder J, Gehr P (eds) Particle lung interactions. Marcel Dekker, New York, USA, pp 323-376.
46. Kreyling WG, Ferron GA, Haider B (1986) Metabolic fate of inhaled Co aerosols in beagle dogs. Health Phys 51:773-795.
47. Kreyling WG, Blanchard JD, Godleski JJ, Haeussermann S, Heyder J, Hutzler P, Schulz H, Sweeney TD, Takenaka S, Ziesenis A (1999) Anatomic localization of 24- And 96-h particle retention in canine airways. J Appl Physiol 87:269-284.
48. Kreyling WG, Takenaka S, Schumann G, Ziesenis A (2001) Particles are predominantly transported from the canine epithelium towards the interstitial spaces and not to larynx! Analogy to human lungs? Am J Respir Crit Care Med 163:A166.
49. Kreyling WG, Semmler M, Erbe F, Mayer P, Takenaka S, Schulz H (2002) Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J Toxicol Environ Health 65:1513-1530.
50. Kreyling WG, Tuch T, Peters A, Pitz M, Heinrich J, Stölzel M, Cyrys J, Heyder J, Wichmann HE (2003) Diverging long-term trends in ambient urban particle mass and number concentrations associated with emission changes caused by the German unification. Atmos Environ 37:3841-3848.
51. Kreyling WG, Semmler M, Moeller W (2004) Dosimetry and toxicology of ultrafine particles. J Aerosol Med 17:140-152.
52. Kreyling WG, Semmler-Behnke M, Moller W (2006a) Ultrafine particle-lung interactions: does size matter? J Aerosol Med 19:74-83.
53. Kreyling WG, Semmler-Behnke M, Moeller W (2006b) Health implications of nanoparticles. J Nanopart Res 8:543-562.
54. Kreyling WG, Möller W, Semmler-Behnke M, Oberdörster G (2007) Particle dosimetry: Deposition and clearance from the respiratory tract and translocation towards extra-pulmonary sites. In: Donaldson K, Borm P (eds) Particle toxicology. CRC, Taylor & Francis, Boca Raton, pp 47-74.
55. Kreyling WG, Semmler-Behnke M, Seitz J, Scymczak W, Wittmaack K, Wenk A, Mayer P, Takenaka S, Oberdörster G (2009) Size and material dependency of Translocation of inhaled iridium or carbon Nanoparticles from the lungs of rats to blood. Inhal Toxicol 21(S1):55-60.
56. Laden F, Neas LM, Dockery DW, Schwartz J (2000) Association of fine particulate matter from different sources with daily mortality in six U.S. cities. Environ Health Perspect 108:941-947.
57. Laden F, Schwartz J, Speizer FE, Dockery DW (2006) Reduction in fine particulate air pollution and mortality: extended follow-up of the Harvard Six Cities study. Am J Respir Crit Care Med 173:667-672.
58. LeFevre ME, Green FH, Joel DD, Laqueur W (1982) Frequency of black pigment in livers and spleens of coal workers: correlation with pulmonary pathology and occupational information. Hum Pathol 13:1121-1126.
59. Lehnert BE, Morrow PE (1985) Association of 59Iron oxide with alveolar macrophages during alveolar clearance. Exp Lung Res 9:1-16.
60. Lehnert BE, Valdez YE, Tietjen GL (1989) Alveolar macrophage-particle relationships during lung clearance. Am J Respir Cell Mol Biol 1:145-154.
61. Lehnert BE, Ortiz JB, London JE, Valdez YE, Cline AF, Sebring RJ, Tietjen GL (1990) Migratory behaviors of alveolar macrophages during the alveolar clearance of light to heavy burdens of particles. Exp Lung Res 16:451-479.
62. Lynch I, Dawson KA (2008) Protein-nanoparticle interactions. Nano Today 3:40-47.
63. Macklin CC (1955) Pulmonary sumps, dust accumulations, alveolar fluid and lymph vessels. Acta Anat 23:1-33.
64. Miller FJ (2000) Dosimetry of particles in laboratory animals and humans in relationship to issues surrounding lung overload and human health risk assessment: a critical review. Inhal Toxicol 12:19-57.
65. Mills NL, Tornqvist H, Robinson SD, Gonzalez M, Darnley K, MacNee W, Boon NA, Donaldson K, Blomberg A, Sandstrom T, Newby DE (2005) Diesel exhaust inhalation causes vascular dysfunction and impaired endogenous fibrinolysis. Circulation 112:3930-3936.
66. Mills NL, Amin N, Robinson SD, Anand A, Davies J, Patel D, de la Fuente JM, Cassee FR, Boon NA, MacNee W, Millar AM, Donaldson K, Newby DE (2006) Do inhaled carbon nanoparticles translocate directly into the circulation in humans? Am J Respir Crit Care Med 173:426-431.
67. Möller W, Felten K, Sommerer K, Scheuch G, Meyer G, Meyer P, Haussinger K, Kreyling WG (2008a) Deposition, retention, and translocation of ultrafine particles from the central airways and lung periphery. Am J Resp Crit Care Med 177:426-432.
68. Möller W, KreylingWG, Schmid O, Semmler-Behnke M, Schulz H (2008b) Deposition, retention and clearance, and translocation of inhaled fine and nano-particles in the respiratory tract. In Gehr P, Blank F, Mühlfeld C, Rothen-Rutishauser B (eds) Particle-Lung Interactions Second Edition, Series: Lung Biology in Health and Disease Volume 241.
69. Nemmar A, Hoylaerts MF, Hoet PH, Dinsdale D, Smith T, Xu, H, Vermylen J, Nemery B (2002) Ultrafine particles affect experimental thrombosis in an in vivo hamster model. Am J Respir Crit Care Med 166:998-1004.
70. Oberdörster G, Sharp Z, Atudorei V, Elder A, Gelein R, Lunts A, Kreyling WG, Cox C (2002) Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J Toxicol Environ Health 65:1531-1543.
71. Oberdörster G, Oberdörster E, Oberdörster J (2005) Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113:823-839.
72. Peters A, Pope CA III (2002) Cardiopulmonary mortality and air pollution. Lancet 360:1184-1185.
73. Pope CA III (2004) Air pollution and health - good news and bad. N Engl J Med 351:1132-1134.
74. Rytting E, Nguyen J, Wang X, Kissel T (2008) Biodegradable polymeric nanocarriers for pulmonary drug delivery. Expert Opin Drug Deliv 5:629-639.
75. Schäffler A, Menche N (1999) Mensch Körper Krankheit. Urban and Fischer, Munich, Germany.
76. Schulz H, Harder V, Ibald-Mulli A, Khandoga A, Koenig W, Krombach F, Radykewicz R, Stampfl A, Thorand B, Peters A (2005) Cardiovascular effects of fine and ultrafine particles. J Aerosol Med 18:1-24.
77. Schürch S, Gehr P, Im Hof V, Geiser M, Green F (1990) Surfactant displaces particles toward the epithelium in airways and alveoli. Respir Physiol 80:17-32.
78. Semmler M, Seitz J, Erbe F, Mayer P, Heyder J, Oberdörster G, Kreyling WG (2004) Long-term clearance kinetics of inhaled ultrafine insoluble iridium particles from the rat lung, including transient translocation into secondary organs. Inhal Toxicol Jun 16:453-459.
79. Semmler-Behnke M, Takenaka S, Fertsch S, Wenk A, Seitz J, Mayer P, Oberdörster G, Kreyling WG (2007a) Efficient elimination of inhaled nanoparticles from the alveolar region: Evidence for interstitial uptake and subsequent reentrainment onto airways epithelia. Environ Health Perspect 115:728-733.
80. Semmler-Behnke M, Fertsch S, Schmid O, Wenk A, Kreyling WG (2007) Uptake of 1.4 mm versus 18mm Gold particles by secondary target organs is size dependent in control and pregnants rats after intertracheal or intravenoiz application. In: Euro nanoforum: nanotechnology in industrial applications, pp 102-104, http://www.euronanoforum2007.de/download/Proceedings%20ENF2007.pdf.
81. Semmler-Behnke M, Bolle I, Moeller W, .Schulz H, Takenaka S, Tsuda A, Kreyling WG (2007) Ultrafine particle deposition differs consistently between the developing and adult rat lung. European Aerosol Conference 2007, Salzburg, Abstract T08A013.
82. Semmler-Behnke M, Kreyling WG, Lipka J, Fertsch S, Wenk A, Takenaka S, Schmid G, Brandau W (2008) Biodistribution of 1.4 nm and 18 nm Gold particles in rats. Small 4(12):2108-2111.
83. Silva VM, Corson N, Elder A, Oberdörster G (2005) The rat ear vein model for investigating in vivo thrombogenicity of ultrafine articles (UFP). Toxicol Sci 85:983-989.
84. Sims DE, Westfall JA, Kiorpes AL, Horne MM (1991) Preservation of tracheal mucus by nonaqueous fixative. Biotech Histochem 66:173-180.
85. Sorokin SP, Brain JD (1975) Pathways of clearance in mouse lungs exposed to iron oxide aerosols. Anat Rec 181:581-626.
86. Sterio DC (1984) The unbiased estimation of number and sizes of arbitrary particles using the disector. J Microsc 134:127-136.
87. Takenaka S, Karg E, Roth C, Schulz H, Ziesenis A, Heinzmann U, Schramel P, Heyder J (2001) Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ Health Perspect 109 (Suppl 4):547-551.
88. Takenaka S, Karg E, Kreyling WG, Lentner B, Moller W, Behnke-Semmler M, Jennen L, Walch A, Michalke B, Schramel P, Heyder J, Schulz H (2006) Distribution pattern of inhaled ultrafine gold particles in the rat lung. Inhal Toxicol 18:733-740.
89. Thurston RJ, Hess RA, Kilburn KH, McKenzie WN (1976) Ultrastructure of lungs fixed in inflation using a new osmium-fluorocarbon technique. J Ultrastruct Res 56:39-47.
90. Weibel ER (1984) Morphometric and stereological methods in respiratory physiology including fixation techniques. In: Otis AB (ed) Techniques in the life sciences. Elsevier Scientific, Ireland, pp 1-35.
91. West MJ, Østergaard K, Andreassen OA, Finsen B (1996) Estimation of the number of somatostatin neurons in the striatum: an in situ hybridization study using the optical fractionator method. J Comp Neurol 370:11-22.
92. Wiebert P, Sanchez-Crespo A, Falk R, Philipson K, Lundin A, Larsson S, Möller W, Kreyling WG, Svartengren M (2006a) No significant translocation of inhaled 35-nm carbon particles to the circulation in humans. Inhal Toxicol 18:741-747.
93. Wiebert P, Sanchez-Crespo A, Seitz J, Falk R, Philipson K, Kreyling WG, Möller W, Sommerer K, Larsson S, Svartengren M (2006b) Negligible clearance of ultrafine particles retained in healthy and affected human lungs. Eur Respir J 28:286-290.
94. Yoneda K (1976) Mucous blanket of rat bronchus. Am Rev Respir Dis 114:837-842.